سعر ايبان 150 مجم 1 قرص 2022

Iban 150 mg film-coated tablet (pack of 1): ibandronic acid, a nitrogen-containing bisphosphonate bone-resorption inhibitor, from Andalous Pharma (Egypt), used for postmenopausal osteoporosis as a once-monthly tablet.

• Treatment and prevention of osteoporosis in postmenopausal womenPopulation: Postmenopausal womenDailyMed (U.S. National Library of Medicine)

• Common reactions in trials included dyspepsia, nausea, diarrhoea, constipation, abdominal pain, arthralgia, back pain, pain in extremity, myalgia, influenza and nasopharyngitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Oesophageal abnormalities delaying emptying (e.g. stricture, achalasia); inability to stand or sit upright for at least 60 minutes; hypocalcaemia; hypersensitivity to ibandronate or excipients.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Upper gastrointestinal irritation (dysphagia, oesophagitis, ulcers) may occur; follow dosing instructions.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Treat hypocalcaemia and other mineral disturbances before starting; ensure adequate calcium and vitamin D.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Severe, occasionally incapacitating bone, joint or muscle pain has been reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Calcium supplements, antacids and other multivalent cations (aluminium, magnesium, iron)Likely to interfere with absorption; take ibandronate at least 60 minutes before any other oral medication.DailyMed (U.S. National Library of Medicine)
• Aspirin / NSAIDsAdditive gastrointestinal irritation; use with caution.DailyMed (U.S. National Library of Medicine)

• Not indicated for women of reproductive potential; no human pregnancy data. In rats, ibandronate caused post-implantation loss and obstruction of labour.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for women of reproductive potential; no information on presence in human milk (present in rat milk).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ibandronic acid: Inhibits osteoclast-mediated bone resorption (bisphosphonate; the Egyptian directory cites farnesyl pyrophosphate synthase inhibition).